DBT supported efficacy trial with recombinant BCG vaccine completes enrolment of 6000 health-workers and high risk individuals
The objective of this trial is to evaluate the ability of VPM1002 in reducing infection incidence and severe disease outcomes of COVID-19 among high-risk persons
Indian Healthcare Angels Forum Launched
Some well- known investors and investment facilitators have launched the Indian Healthcare Angels (IHA) Forum to bring in aspiring Angels and Angel investors to look at investing in Indian healthcare startups with a much more commitment in midst of the Corona Pandemic.
Serum Institute’s Adar Poonawalla hopes to launch COVID-19 vaccine by November
Mr Poonawalla had told NDTV that the vaccine will take probably two to two-and-half months to complete. He is hopeful that the vaccine will be launched by November, if the trials are positive and if the regulatorDCGI approves it.